About
Dr Rita Lim: Rita has 10 years of pharmaceutical drug discovery research experience in multiple roles, including Principal Investigator, Senior Scientist, Project Leader, and Lab Manager. During Rita’s research career, she initiated multiple projects, including falcipain (malaria) and hepatitis C NS3-4a protease which resulted in a successful partnership with Schering-Plough and the discovery and development of bocepravir, a first-in-class cure in combination therapy for hepatitis. Most recently, Rita has taken various roles in the business of science, from product marketing, product management, business development, support, and sales. Rita serves as Senior Director, Business Development for Proteros US, a contract research organization that provides structures and data for drug discovery.
Rita has been successful in obtaining an SBIR grant for inhibitors of falcipain as antimalarials, co-authored 21 papers and is a co-inventor on 11 patents and two book chapters. Rita is co-editor of the book series Pharmaceutical Outsourcing: Discovery and Preclinical Services.
Rita is Founder of PGC200, a non-profit organization dedicated to learning and networking for life science professionals. She is on the Industry Advisory Board for the Southern California Biotech Center. Rita was previously co-Chair of the Education and Career Development Committee at SABPA, Board Director and Chair of the Science and Medicine Committee with Susan G. Komen for the Cure San Diego .
Joined
September 2012
